IPOs

IPOs vs SPACs
EP Vantage
Thu, 03/9/23 - 09:47 am
IPOs
SPAC
Belite Bio
Cerevel Therapeutics
NewAmsterdam Pharma
Nuvectis Pharma
Oculis
Roivant Sciences
A small Connecticut biotech throws hat into IPO ring
Endpoints
Tue, 02/21/23 - 04:28 pm
Azitra
IPOs
skin diseases
dermatology
IPO Doors Creak Open as Mineralys Seeks $192M
BioSpace
Fri, 02/10/23 - 10:31 am
IPOs
Mineralys Therapeutics
hypertension
MLS-101
Swiss rare disease biotech withdraws IPO to update its Nasdaq plans
Endpoints
Wed, 02/8/23 - 10:30 am
Relief Therapeutics
IPOs
Biotech startup Structure pulls off rare IPO, raising $161M
BioPharma Dive
Fri, 02/3/23 - 10:34 am
IPOs
Structure Therapeutics
Biotech CFOs eye research cuts, partnerships amid sector retrenchment: report
BioPharma Dive
Mon, 01/30/23 - 10:52 am
biotech
CFOs
R&D
funding
IPOs
Mineralys polishes $100M IPO plans ahead of phase 3 in hypertension
Fierce Biotech
Thu, 01/19/23 - 09:59 am
IPOs
Mineralys
hypertension
5 questions facing emerging biotech in 2023
BioPharma Dive
Tue, 01/10/23 - 06:44 pm
biotech
IPOs
platform companies
funding
restructuring
Inflation Reduction Act
Ready for takeoff: J&J's consumer health unit Kenvue files for official separation
Endpoints
Thu, 01/5/23 - 05:02 pm
JNJ
IPOs
consumer health
Kenvue
spinoffs
IPOs fail to bounce back in Q4
EP Vantage
Thu, 01/5/23 - 10:16 am
IPOs
Prime Medicine
Acrivon Therapeutics
Lipella Pharmaceuticals
Disappearing IPOs, building startups and closing deals: Views from an up-and-down year in biotech
BioPharma Dive
Tue, 01/3/23 - 10:03 am
IPOs
venture capital
funding
Health tech companies weigh funding options amid weak IPO market
BioPharma Dive
Tue, 11/22/22 - 11:06 am
Medtech
IPOs
pandemic
inflattion
Acrivon Nets $100M for Protein Tech That Picks Patients for Targeted Cancer Meds
MedCity News
Sun, 11/20/22 - 12:37 pm
Acrivon Therapeutics
Eli Lilly
IPOs
Proteomics
cancer
oncology
Acrivon Becomes Biotech's 20th IPO of 2022 with $99M Offering
BioSpace
Tue, 11/15/22 - 06:36 pm
Acrivon Therapeutics
IPOs
Prime time for IPO as gene editing biotech goes public with $175M
Fierce Biotech
Thu, 10/20/22 - 11:26 pm
Prime Medicine
IPOs
gene editing
A startup plans an IPO to give a shelved Lilly drug another shot
BioPharma Dive
Wed, 10/19/22 - 10:39 am
Acrivon Therapeutics
IPOs
Eli Lilly
prexasertib
ovarian cancer
endometrial cancer
bladder cancer
precision medicine
The biopharma flotation remains a rare beast
EP Vantage
Tue, 10/4/22 - 10:40 am
IPOs
Paxmedica
Maia Biotechnology
Third Harmonic Bio
Prime Medicine becomes the next high-profile biotech to test the IPO waters
BioPharma Dive
Mon, 09/26/22 - 11:33 pm
Prime Medicine
IPOs
gene editing
Can biotech IPOs bounce back? Third Harmonic to test investor appetite with planned offering
BioPharma Dive
Wed, 09/14/22 - 10:11 am
IPOs
biotech
Third Harmonic Bio
Targeting Novo Nordisk in China's obesity market with a unique proposition, LeaderMed eyes US IPO
Fierce Biotech
Fri, 09/2/22 - 12:32 pm
Novo Nordisk
obesity
China
IPOs

Pages